Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: 10Q.... Warrants outstanding...--from last 10-q
Three Months Ended August 31, 2006
 
   
Numerator
(Income)
Denominator
(Shares)
Per Share
Amount
 
Basic EPS:
                   
Net income
 
$
5,990,273
   
368,837,051
 
$
0.02
 
Diluted EPS:
                   
Effect of dilutive securities:
                   
Options and warrants
   
-
   
51,809,718
       
Income available to common stockholders
 
$
5,990,273
   
420,646,769
 
$
0.01

http://yahoo.brand.edgar-online.com/fetchFilingFrameset.aspx?dcn=0001144204-06-043274&Type=HTML

 

Share
New Message
Please login to post a reply